DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Non-Small-Cell Lung Cancer – Current Treatment – Current Treatment: Physician Insights – Non-Small-Cell Lung Cancer (US)
Immune checkpoint inhibitors continue to anchor the treatment of non-small-cell lung cancer (NSCLC), while rapid advances in biomarker-driven strategies are accelerating patient segmentation and…
Dry and Wet Age-Related Macular Degeneration – Unmet Need – Unmet Need – Wet Age-Related Macular Degeneration (US/EU)
Wet AMD (age-related macular degeneration) is a leading cause of vision loss among older adults, with significant implications on patient’s independence and quality of life. The treatment…
Crohn’s Disease – Unmet Need – Unmet Need – Moderate to Severe Crohn’s Disease (US/EU)
Crohn’s disease (CD) is a chronic inflammatory bowel disorder characterized by diarrhea, abdominal pain, and weight loss. Tumor necrosis factor (TNF)-α inhibitors, such as Johnson & Johnson…
Non-Small-Cell Lung Cancer – Current Treatment – Treatment Sequencing – Non-Small-Cell Lung Cancer (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…
Painful Diabetic Neuropathy – Unmet Need – Unmet Need – Painful Diabetic Neuropathy (US/EU)
Painful diabetic neuropathy (PDN) is a prevalent complication of chronic diabetes, inducing enduring and often intense pain, characterized by sensations of burning, stabbing, tingling, and…
Diabetic Retinopathy – Epidemiology – Epidemiology – Diabetic Retinopathy – Mature Markets
Clarivate Epidemiology’s coverage of diabetic retinopathy comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
